Cargando…
Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma()()
Therapeutic strategies that act by eliciting and enhancing antitumor immunity have been clinically validated as an effective treatment modality but may benefit from the induction of both cell death and immune activation as primary stimuli. Using our AdRGD-PG adenovector platform, we show here for th...
Autores principales: | Catani, João Paulo Portela, Medrano, Ruan F.V., Hunger, Aline, Del Valle, Paulo, Adjemian, Sandy, Zanatta, Daniela Bertolini, Kroemer, Guido, Costanzi-Strauss, Eugenia, Strauss, Bryan E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143354/ https://www.ncbi.nlm.nih.gov/pubmed/27916291 http://dx.doi.org/10.1016/j.tranon.2016.09.011 |
Ejemplares similares
-
Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy
por: Hunger, Aline, et al.
Publicado: (2017) -
Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death
por: Hunger, Aline, et al.
Publicado: (2017) -
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
por: Medrano, Ruan F.V., et al.
Publicado: (2017) -
Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy
por: Medrano, Ruan F. V., et al.
Publicado: (2022) -
Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer
por: Strauss, Bryan E, et al.
Publicado: (2018)